CS9101451A2 - Method of phenylisoserine derivatives stereoselective preparation - Google Patents

Method of phenylisoserine derivatives stereoselective preparation

Info

Publication number
CS9101451A2
CS9101451A2 CS911451A CS145191A CS9101451A2 CS 9101451 A2 CS9101451 A2 CS 9101451A2 CS 911451 A CS911451 A CS 911451A CS 145191 A CS145191 A CS 145191A CS 9101451 A2 CS9101451 A2 CS 9101451A2
Authority
CS
Czechoslovakia
Prior art keywords
pct
phenylisoserine
date nov
sec
reacted
Prior art date
Application number
CS911451A
Other languages
English (en)
Inventor
Arlene Correa
Jean-Noel Denis
Andrew-Elliot Greene
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of CS9101451A2 publication Critical patent/CS9101451A2/cs
Publication of CZ279927B6 publication Critical patent/CZ279927B6/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/16Preparation of optical isomers
    • C07C231/18Preparation of optical isomers by stereospecific synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Indole Compounds (AREA)
  • Epoxy Compounds (AREA)
CS911451A 1990-05-22 1991-05-16 Způsob stereoselektivní přípravy derivátů fenylisoserinu CZ279927B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9006368A FR2662440B1 (fr) 1990-05-22 1990-05-22 Procede de preparation stereoselective de derives de la phenylisoserine.

Publications (2)

Publication Number Publication Date
CS9101451A2 true CS9101451A2 (en) 1991-12-17
CZ279927B6 CZ279927B6 (cs) 1995-08-16

Family

ID=9396838

Country Status (23)

Country Link
US (1) US5290957A (cs)
EP (1) EP0530286B1 (cs)
JP (1) JPH05506864A (cs)
AT (1) ATE109456T1 (cs)
AU (1) AU648319B2 (cs)
CA (1) CA2079313A1 (cs)
CZ (1) CZ279927B6 (cs)
DE (1) DE69103265T2 (cs)
DK (1) DK0530286T3 (cs)
ES (1) ES2057899T3 (cs)
FI (1) FI924568L (cs)
FR (1) FR2662440B1 (cs)
HU (1) HU212728B (cs)
IE (1) IE64276B1 (cs)
IL (1) IL98190A (cs)
NO (1) NO179942C (cs)
NZ (1) NZ238206A (cs)
PT (1) PT97745B (cs)
RU (1) RU2091368C1 (cs)
SK (1) SK277925B6 (cs)
WO (1) WO1991017977A1 (cs)
YU (1) YU89691A (cs)
ZA (1) ZA913828B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658510B1 (fr) * 1990-02-21 1992-04-30 Rhone Poulenc Sante Nouveau derive de la beta-phenylisoserine, sa preparation et son emploi.
CA2092705C (en) * 1991-07-17 1995-11-07 Koji Saito Compound having antitumor activity, nsc-lsc1, and process for producing the same
FR2680506B1 (fr) * 1991-08-19 1994-09-02 Rhone Poulenc Rorer Sa Procede de preparation de derives de la beta-phenylisoserine et leur utilisation.
US6018073A (en) * 1991-09-23 2000-01-25 Florida State University Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
US5739362A (en) * 1991-09-23 1998-04-14 Florida State University Taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
KR960006762B1 (ko) * 1992-02-29 1996-05-23 삼성전자주식회사 화상부호화를 위한 효율적인 2차원 데이타의 주사선택회로
FR2696454B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation stéréosélective d'un dérivé de la beta-phénylisosérine et son utilisation pour la préparation de dérivés du Taxane.
MX9307777A (es) 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
PT982301E (pt) * 1993-06-11 2004-02-27 Upjohn Co Utilizacao antineoplasica de delta-6,7-taxois e composicoes farmaceuticas que oscontem
US6005120A (en) * 1993-07-20 1999-12-21 Florida State University Tricyclic and tetracyclic taxanes
US5405972A (en) * 1993-07-20 1995-04-11 Florida State University Synthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanes
IL127598A (en) * 1994-01-28 2003-04-10 Upjohn Co Process for preparing isotaxol analogs
WO1998049321A2 (en) * 1997-04-28 1998-11-05 Rhone-Poulenc Rorer S.A. Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
FR2794771B1 (fr) * 1999-06-11 2001-08-10 Aventis Pharma Sa Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
WO2011035569A1 (en) * 2009-09-23 2011-03-31 Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Process for manufacture of n-acylbphenyl alanine
DK2753355T3 (en) 2011-09-08 2019-01-28 Univ New York ONCOLYTIC HERP SIMPLEX VIRUSES AND THERAPEUTIC APPLICATIONS THEREOF
WO2013096455A1 (en) 2011-12-20 2013-06-27 Dana-Farber Cancer Institute, Inc. Methods for diagnosing and treating oncogenic kras-associated cancer
US10138479B2 (en) 2012-05-24 2018-11-27 Dana-Farber Cancer Institute, Inc. Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
US20150285802A1 (en) 2012-07-18 2015-10-08 Dana-Farber Cancer Institute, Inc. Methods for treating, preventing and predicting risk of developing breast cancer
EP2968406A4 (en) 2013-03-14 2016-10-26 Icahn School Med Mount Sinai WITH AUTOLOGOUS TUMORLYSAT-LOADED DENDRITIC CELL VACCINE FOR THE TREATMENT OF LIVER CANCER
US10130590B2 (en) 2013-10-01 2018-11-20 Dana-Farber Cancer Institute, Inc. Methods of treating cancer with atovaquone-related compounds
WO2015149006A2 (en) 2014-03-27 2015-10-01 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating ncoa4-mediated autophagic targeting of ferritin
MA39818A (fr) 2014-03-30 2017-02-08 Benevir Biopharm Inc Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
US10967015B2 (en) 2015-06-15 2021-04-06 New York University Method of treatment using oncolytic viruses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4775782A (en) * 1987-09-30 1988-10-04 Ncr Corporation Checkout counter with remote keyboard writing pad and display
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
IL95436A (en) * 1989-08-23 1996-07-23 Centre Nat Rech Scient Method for the preparation of phenzlisoserine derivatives

Also Published As

Publication number Publication date
SK277925B6 (en) 1995-08-09
NZ238206A (en) 1993-05-26
NO179942B (no) 1996-10-07
EP0530286A1 (fr) 1993-03-10
ZA913828B (en) 1992-02-26
IL98190A (en) 1995-12-31
DK0530286T3 (da) 1994-09-12
FI924568A0 (fi) 1992-10-09
DE69103265D1 (de) 1994-09-08
HUT62260A (en) 1993-04-28
FI924568A7 (fi) 1992-10-09
ES2057899T3 (es) 1994-10-16
NO179942C (no) 1997-01-15
NO924488L (no) 1992-11-20
IE911737A1 (en) 1991-12-04
FR2662440B1 (fr) 1992-07-31
JPH05506864A (ja) 1993-10-07
AU648319B2 (en) 1994-04-21
NO924488D0 (no) 1992-11-20
YU89691A (sh) 1994-01-20
HU9203651D0 (en) 1993-03-29
IL98190A0 (en) 1992-06-21
DE69103265T2 (de) 1994-12-22
US5290957A (en) 1994-03-01
CA2079313A1 (fr) 1991-11-23
RU2091368C1 (ru) 1997-09-27
IE64276B1 (en) 1995-07-26
CZ279927B6 (cs) 1995-08-16
EP0530286B1 (fr) 1994-08-03
HU212728B (en) 1996-10-28
PT97745B (pt) 1998-10-30
PT97745A (pt) 1992-02-28
WO1991017977A1 (fr) 1991-11-28
AU7969391A (en) 1991-12-10
FI924568L (fi) 1992-10-09
ATE109456T1 (de) 1994-08-15
FR2662440A1 (fr) 1991-11-29

Similar Documents

Publication Publication Date Title
CS9101451A2 (en) Method of phenylisoserine derivatives stereoselective preparation
GB9114948D0 (en) Process for preparing sertraline intermediates
AU7116691A (en) Process for the preparation of oxetanones
CA2105251A1 (en) Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
TW263499B (cs)
HU9203650D0 (en) Method for enanthio-selective production of phenyl-isosterine derivatives
MX9601105A (es) Proceso para la preparacion de etil-n-(2,3-dicloro-6-nitrobencil)glicina.
GR3017766T3 (en) Process for preparing sertraline.
AU3804195A (en) Process for the preparation of substituted 3-aminobnzonitriles
AU2808892A (en) Process for preparing (s) (+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione)
HUT53103A (en) Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients
EG20562A (en) Process for preparing glutaramide derivatives
TW339325B (en) Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same
ATE173259T1 (de) Verfahren zur herstellung von indolizinderivaten
ATE188694T1 (de) Verfahren zur herstellung von benzopyranderivaten
ATE159517T1 (de) Verfahren zur herstellung von n-carbonylarylimine als zwischenprodukte in der synthese von therapeutisch aktiven taxol-derivaten
JPS55164671A (en) Azetidine derivative and its preparation
MX9700331A (es) Proceso mejorado para r(+)1,2,3,6-tetrahidro-4-fenil-1-[(3-fenil-3-ciclohexen-1-il)metil]pirid ina, un agente del sistema nervioso central.
JPS5655385A (en) Novel sesquiterpene derivative
JPS57166986A (en) Preparation of antibiotic substance
JPS5419956A (en) Novel bicyclooctane derivative and its preparation
MX9605321A (es) Proceso para la preparacion de 4-amino-a4-amino-a3-cetoesteroides via 4-nitro-a4-cetoesteroides.